You are encouraged to report suspected illegal or wrongful content or actions to:

  1. This email legal notice is enforceable and binding on the recipient / addressee in terms of sections 11(1) to 11(3) of the Electronic Communications and Transactions Act 25 of 2002.
  2. This email transmission contains confidential information, which is the property of Cryo-Save South Africa (Pty) Limited, Salveo Swiss Biotechnology (Pty) Ltd or Ecsponent Biotech (Pty) Ltd, as administered by the Ecsponent Group. No person, other than the recipient (so indicated by the sender) may use or disclose the contents of this message, links or attachments hereto to any person whatsoever. Disclosure and/or unauthorised use may lead to civil liability.
  3. The information in this email or attachments thereto is intended for the attention and use only of the addressee. If you are not the intended recipient, you are hereby notified that any disclosure, copying or distribution of the contents of this email transmission, or the taking of any action in reliance thereon or pursuant thereto, is strictly prohibited. Should you have received this email in error, please delete and destroy it and any attachments thereto immediately. At no time, may you act on the information contained therein.
  4. The email address of the sender may not be used, copied, sold, disclosed or incorporated into any database or mailing list for spamming and/or other marketing practices without the prior written consent of the sender.
  5. Under no circumstances shall Cryo-Save South Africa (Pty) Limited, Salveo Swiss Biotechnology (Pty) Ltd or Ecsponent Biotech Pty (Ltd), as administered by the Ecsponent Group or the sender of this email be liable to any party for any direct, indirect, special or other consequential damages for any use of this email, or of any other hyper linked web site, including, without limitation, any lost profits, business interruption, loss of programs or other data on information handling systems or otherwise, even if Cryo-Save South Africa (Pty) Limited, as administered by the Ecsponent Group or the sender of this email have been expressly advised of the possibility of such damages.
  6. Any agreements concluded with Cryo-Save South Africa (Pty) Limited, Salveo Swiss Biotechnology (Pty) Ltd or Ecsponent Biotech Pty (Ltd), as administered by the Ecsponent Group by using electronic correspondence shall only come into effect once any of the aforementioned companies administered by the Ecsponent Group indicated such contract formation in a written follow up communication.
  7. No email correspondence sent to any of the aforementioned companies administered by the Ecsponent Group shall be deemed to have been received until the recipient company, administered by the Ecsponent Group has responded thereto in writing. An auto-reply shall not constitute such a response.
  8. No warranties are made or implied that any employee or contractor of Cryo-Save South Africa (Pty) Limited, Salveo Swiss Biotechnology (Pty) Ltd or Ecsponent Biotech Pty (Ltd), as administered by the Ecsponent Group was authorised to make this communication.
  9. All the aforementioned companies as administered by the Ecsponent Group retain the copyright in all email messages and attachments sent from their communications systems. You are hereby licensed to open and read the message and/or attachments only – all other rights are reserves unless so indicated by the sender.
  10. The views and opinions expressed in this email do not necessarily express or reflect the views and/or opinions of the aforementioned companies, as administered by the Ecsponent Group. If this email message was used for purposes unrelated to the official business of the aforementioned companies, as administered by the Ecsponent Group, none of the aforementioned companies, as administered by the Ecsponent Group shall be liable for any damage caused by the contents of such a message and the sender shall take full responsibility therefor in his/her sole and personal capacity.
  11. Subject to urgent and interim court relief, all disputes and/or disagreements and/or damages and/or liabilities, in any manner related to the following:
    1. Interpretation and enforceability of this email legal notice;
    2. Interpretation of this email legal notice;
    3. Content (including message headers, links and/or attachments) of this email message; or
    4. Sending or receipt of this email message shall be referred to urgent and confidential arbitration in terms of the expedited arbitration rules of the South African Arbitration Foundation and such arbitration shall be conducted in Pretoria in English.
  1. The law of South Africa governs this email legal notice.
  2. Information disclosures required by law:
    1. Full name of company: Cryo-Save South Africa (Pty) Limited, registration number: 2010/009754/07
    2. Salveo Swiss Biotechnology (Pty) Ltd, registration number:
    3. Ecsponent Biotech (Pty) Ltd, registration number:
    4. Postal address for aforementioned companies: PO Box 39660, Garsfontein East, 0060
    5. Street address for aforementioned companies: Ground Floor, Acacia House, Green Hill Village Office Park, Lynnwood Road, corner of Botterklapper & Nentabos Streets, The Willows, Pretoria East, Gauteng South Africa
    6. Web sites: www.cryo-save.co.za, www.salveobiotech.co.za and www.ecsbio.com
  1. This email legal notice shall at all times take precedence over any other email disclaimer(s) received by employees or contractors utilising the communications facilities of the aforementioned companies, as administered by the Ecsponent Group.
  2. Cryo-Save South Africa (Pty) Limited, Salveo Swiss Biotechnology (Pty) Ltd or Ecsponent Biotech Pty (Ltd), as administered by the Ecsponent Group retain the copyright in this email legal notice. © 2017, ALL RIGHTS RESERVED. Copying, distribution or use of this notice, in whole or in part, shall result in civil and criminal action.